Primary Recipient

MACROGENICS, INC.

Amount

$2,999,972.00

Award Date

6/07/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The product under consideration, a molecule called CD32BxCD79B, represents a novel approach to countering the function of cells of the immune system that are responsible for autoimmune diseases, such as rheumatoid arthritis (RA), systemic lupus erythemato